These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24657947)

  • 1. Ultrasound-assisted siRNA delivery via arginine-grafted bioreducible polymer and microbubbles targeting VEGF for ovarian cancer treatment.
    Florinas S; Kim J; Nam K; Janát-Amsbury MM; Kim SW
    J Control Release; 2014 Jun; 183():1-8. PubMed ID: 24657947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced siRNA delivery using a combination of an arginine-grafted bioreducible polymer, ultrasound, and microbubbles in cancer cells.
    Florinas S; Nam HY; Kim SW
    Mol Pharm; 2013 May; 10(5):2021-30. PubMed ID: 23527953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGF siRNA delivery system using arginine-grafted bioreducible poly(disulfide amine).
    Kim SH; Jeong JH; Kim TI; Kim SW; Bull DA
    Mol Pharm; 2009; 6(3):718-26. PubMed ID: 19055368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginine-engrafted biodegradable polymer for the systemic delivery of therapeutic siRNA.
    Beloor J; Choi CS; Nam HY; Park M; Kim SH; Jackson A; Lee KY; Kim SW; Kumar P; Lee SK
    Biomaterials; 2012 Feb; 33(5):1640-50. PubMed ID: 22112761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-weight polyethylenimine cross-linked 2-hydroxypopyl-β-cyclodextrin and folic acid as an efficient and nontoxic siRNA carrier for gene silencing and tumor inhibition by VEGF siRNA.
    Li JM; Wang YY; Zhang W; Su H; Ji LN; Mao ZW
    Int J Nanomedicine; 2013; 8():2101-17. PubMed ID: 23766646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.
    Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A
    J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatoma targeting peptide conjugated bio-reducible polymer complexed with oncolytic adenovirus for cancer gene therapy.
    Choi JW; Kim HA; Nam K; Na Y; Yun CO; Kim S
    J Control Release; 2015 Dec; 220(Pt B):691-703. PubMed ID: 26437261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioreducible branched poly(modified nona-arginine) cell-penetrating peptide as a novel gene delivery platform.
    Yoo J; Lee D; Gujrati V; Rejinold NS; Lekshmi KM; Uthaman S; Jeong C; Park IK; Jon S; Kim YC
    J Control Release; 2017 Jan; 246():142-154. PubMed ID: 27170226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a Biocompatible Copolymer Nanocomplex to Deliver VEGF siRNA for Triple Negative Breast Cancer.
    Zhao Z; Li Y; Shukla R; Liu H; Jain A; Barve A; Cheng K
    Theranostics; 2019; 9(15):4508-4524. PubMed ID: 31285776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor targeting RGD conjugated bio-reducible polymer for VEGF siRNA expressing plasmid delivery.
    Kim HA; Nam K; Kim SW
    Biomaterials; 2014 Aug; 35(26):7543-52. PubMed ID: 24894645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-delivery of VEGF and Bcl-2 dual-targeted siRNA polymer using a single nanoparticle for synergistic anti-cancer effects in vivo.
    Lee SJ; Yook S; Yhee JY; Yoon HY; Kim MG; Ku SH; Kim SH; Park JH; Jeong JH; Kwon IC; Lee S; Lee H; Kim K
    J Control Release; 2015 Dec; 220(Pt B):631-41. PubMed ID: 26307351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumor effects of anti-VEGF siRNA encapsulated with PLGA microspheres in mice.
    Murata N; Takashima Y; Toyoshima K; Yamamoto M; Okada H
    J Control Release; 2008 Mar; 126(3):246-54. PubMed ID: 18215787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly effective antiangiogenesis via magnetic mesoporous silica-based siRNA vehicle targeting the VEGF gene for orthotopic ovarian cancer therapy.
    Chen Y; Wang X; Liu T; Zhang DS; Wang Y; Gu H; Di W
    Int J Nanomedicine; 2015; 10():2579-94. PubMed ID: 25848273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of tumor growth in lung cancer xenograft model mice by poly(sorbitol-co-PEI)-mediated delivery of osteopontin siRNA.
    Cho WY; Hong SH; Singh B; Islam MA; Lee S; Lee AY; Gankhuyag N; Kim JE; Yu KN; Kim KH; Park YC; Cho CS; Cho MH
    Eur J Pharm Biopharm; 2015 Aug; 94():450-62. PubMed ID: 26141346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginine-grafted bioreducible poly(disulfide amine) for gene delivery systems.
    Kim TI; Ou M; Lee M; Kim SW
    Biomaterials; 2009 Feb; 30(4):658-64. PubMed ID: 19007981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential and advances in RNAi therapy: chemical and structural modifications of siRNA molecules and use of biocompatible nanocarriers.
    Joo MK; Yhee JY; Kim SH; Kim K
    J Control Release; 2014 Nov; 193():113-21. PubMed ID: 24862319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient siRNA delivery using water soluble lipopolymer for anti-angiogenic gene therapy.
    Kim WJ; Chang CW; Lee M; Kim SW
    J Control Release; 2007 Apr; 118(3):357-63. PubMed ID: 17313987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arginine-grafted biodegradable polymer: a versatile transfection reagent for both DNA and siRNA.
    Beloor J; Nam HY; Lee SK; Kumar P
    Methods Mol Biol; 2014; 1176():115-26. PubMed ID: 25030923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound-responsive microbubbles for sonography-guided siRNA delivery.
    Wang P; Yin T; Li J; Zheng B; Wang X; Wang Y; Zheng J; Zheng R; Shuai X
    Nanomedicine; 2016 May; 12(4):1139-1149. PubMed ID: 26733262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.